Selected Atlases of Gastrointestinal Scintigraphy is com- prised of five individual atlases in the reas of cholescintigraphy; gastrointestinal bleeding (RBC) scintigraphy; TC-99M labeled red blood cell liver scintigraphy; hepatic arterial perfusion scintigraphy and peritoneoscintigraphy.

Each volume in the "Atlases of Clinical Nuclear Medicine" covers one anatomic region or system. Each atlas is extensively illustrated with superb quality images and reveals the spectrum of normal scintigraphic findings as well as examples of both common and unusual conditions. Detailed figure legends describe the findings within each image, and most discuss the image's important teaching point. The text, which is descriptive yet concise, covers such topics as procedure technique, dosimetry, physiology, and scan interpretations. Selected Atlases of Bone Scintigraphy is comprised of four individual atlases in the areas of 1) Skeletal Trauma 2) SPECT Cross Sectional Anatomy of the Normal Spine, Pelvis, Hips, and Skull 3) SPECT Quality control 4) Normal Bone Scintigraphy and Indium-11 White Blood Cell Scintigraphy in Porous Coated Hip Prosthesis

are new to this edition. The authors provide not only the The second edition of Thyroid Cancer: A Comp- most current review of their respective areas, but also their hensive Guide to Clinical Management marks the pub- own recommendations and approach. The reader is fo- cation of a markedly updated and expanded volume that warned that in many cases these approaches, albeit rooted covers all aspects of the etiology, pathogenesis, diag- sis, initial treatment, and long-term management of all in available data, may be empiric rather than based varieties of thyroid cancer. Like the first edition, it will upon clear-cut results of well-controlled clinical t- als. Nevertheless, controversial issues are examined serve as a valuable reference source for pathologists, and evidence-based recommendations are presented endocrine surgeons, endocrinologists, nuclear medicine when available. physicians, and oncologists. However, the biggest There are updated chapters on our current state change is that the second edition is significantly enlarged and expanded to encompass important and extensive of knowledge of the molecular changes in thyroid treatments of more topics related to nuclear medicine. cancer, molecular markers, and how targeted the- pies are being developed. New therapeutic trials of Nuclear medicine physicians and procedures play a key redifferentiation agents to restore the sodium iodide role in the management of thyroid cancer patients and in symporter when lacking and more traditional che- retrospect, a comprehensive discussion of topics related therapies are discussed, with referral sources listed for to that field was somewhat lacking in the first edition.